| Trial Identifier: | 9785-CL-0232 |
| Sponsor: | Astellas Pharma Inc. |
| Start Date: | April 2014 |
| Primary Completion Date: | September 2015 |
| Study Completion Date: | July 2024 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Country | Location |
|---|---|
| China | Beijing, China |
| China | Changsha, China |
| China | Hangzhou, China |
| China | Shanghai, China |
| China | Soochow, China |
| China | Tianjin, China |
| China | Wenzhou, China |
| China | Wu Han, China |
| China | Xi'an, China |
| Hong Kong | Hong Kong, Hong Kong |
| Korea (Republic of) | Anyang, Korea (Republic of) |
| Korea (Republic of) | Busan, Korea (Republic of) |
| Korea (Republic of) | Cheongju, Korea (Republic of) |
| Korea (Republic of) | Daegu, Korea (Republic of) |
| Korea (Republic of) | Daejeon, Korea (Republic of) |
| Korea (Republic of) | Incheon, Korea (Republic of) |
| Korea (Republic of) | Seongnam-si, Korea (Republic of) |
| Korea (Republic of) | Seoul, Korea (Republic of) |
| Taiwan, Province of China | Kaohsiung, Taiwan, Province of China |
| Taiwan, Province of China | Taichung, Taiwan, Province of China |
| Taiwan, Province of China | Tainan, Taiwan, Province of China |
| Taiwan, Province of China | Taipei, Taiwan, Province of China |
| Taiwan, Province of China | Taoyuan County, Taiwan, Province of China |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company